The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pneumonia-Global Market Insights and Sales Trends 2024
Synopsis
Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
The global Pneumonia market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pneumonia in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Pneumonia market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pneumonia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pneumonia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pneumonia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pneumonia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pneumonia covered in this report include Pfizer, GlaxoSmithKline(GSK), Merck, Novartis, Sanofi and Eli Lilly, etc.
The global Pneumonia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
Global Pneumonia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pneumonia market, Segment by Type:
Drugs
Vaccines
Oxygen Therapy
Global Pneumonia market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pneumonia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
The global Pneumonia market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pneumonia in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Others,, are propelling Pneumonia market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pneumonia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pneumonia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pneumonia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pneumonia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pneumonia covered in this report include Pfizer, GlaxoSmithKline(GSK), Merck, Novartis, Sanofi and Eli Lilly, etc.
The global Pneumonia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
Global Pneumonia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pneumonia market, Segment by Type:
Drugs
Vaccines
Oxygen Therapy
Global Pneumonia market, by Application
Hospitals
Ambulatory Surgical Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pneumonia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pneumonia
1.1 Pneumonia Market Overview
1.1.1 Pneumonia Product Scope
1.1.2 Pneumonia Market Status and Outlook
1.2 Global Pneumonia Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pneumonia Market Size by Region (2018-2029)
1.4 Global Pneumonia Historic Market Size by Region (2018-2023)
1.5 Global Pneumonia Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pneumonia Market Size (2018-2029)
1.6.1 North America Pneumonia Market Size (2018-2029)
1.6.2 Europe Pneumonia Market Size (2018-2029)
1.6.3 Asia-Pacific Pneumonia Market Size (2018-2029)
1.6.4 Latin America Pneumonia Market Size (2018-2029)
1.6.5 Middle East & Africa Pneumonia Market Size (2018-2029)
2 Pneumonia Market by Type
2.1 Introduction
2.1.1 Drugs
2.1.2 Vaccines
2.1.3 Oxygen Therapy
2.2 Global Pneumonia Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pneumonia Historic Market Size by Type (2018-2023)
2.2.2 Global Pneumonia Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pneumonia Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pneumonia Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pneumonia Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pneumonia Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pneumonia Revenue Breakdown by Type (2018-2029)
3 Pneumonia Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Pneumonia Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pneumonia Historic Market Size by Application (2018-2023)
3.2.2 Global Pneumonia Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pneumonia Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pneumonia Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pneumonia Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pneumonia Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pneumonia Revenue Breakdown by Application (2018-2029)
4 Pneumonia Competition Analysis by Players
4.1 Global Pneumonia Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia as of 2022)
4.3 Date of Key Players Enter into Pneumonia Market
4.4 Global Top Players Pneumonia Headquarters and Area Served
4.5 Key Players Pneumonia Product Solution and Service
4.6 Competitive Status
4.6.1 Pneumonia Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Pneumonia Products, Services and Solutions
5.1.4 Pfizer Pneumonia Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 GlaxoSmithKline(GSK)
5.2.1 GlaxoSmithKline(GSK) Profile
5.2.2 GlaxoSmithKline(GSK) Main Business
5.2.3 GlaxoSmithKline(GSK) Pneumonia Products, Services and Solutions
5.2.4 GlaxoSmithKline(GSK) Pneumonia Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline(GSK) Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Pneumonia Products, Services and Solutions
5.3.4 Merck Pneumonia Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Pneumonia Products, Services and Solutions
5.4.4 Novartis Pneumonia Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Pneumonia Products, Services and Solutions
5.5.4 Sanofi Pneumonia Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Pneumonia Products, Services and Solutions
5.6.4 Eli Lilly Pneumonia Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
6 North America
6.1 North America Pneumonia Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pneumonia Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pneumonia Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pneumonia Market Dynamics
11.1 Pneumonia Industry Trends
11.2 Pneumonia Market Drivers
11.3 Pneumonia Market Challenges
11.4 Pneumonia Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
